In our study, the relative risk of symptomatic cholelithiasis was 1.6, 1.4, and 0.9 in liraglutide, Semaglutide, and dulaglutide versus control group, with the number needed to harm of 3.14, 5.56, and 16.6, respectively
Given the potential for GLP-1 RA to affect heart rates [30], a meta-analysis of 43 RCTs using GLP-1 RAs showed no increased risk of AF with GLP-1 RAs [39]
Together, total weight reduction would be driven by Retatrutide while Tesamorelin accelerates the breakdown of the most metabolically dangerous fat deposits
Many of our patients eligible for Mounjaro can also switch to Wegovy, but your doctor will always check to make sure its safe and suitable for you before approving your switch